Skip to main content
Premium Trial:

Request an Annual Quote

Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA

NEW YORK – Mammoth Biosciences announced on Monday that it has received Emergency Use Authorization from the US Food and Drug Administration for a high-throughput SARS-CoV-2 assay utilizing CRISPR technology.

Called the DETECTR Boost SARS-CoV-2 Reagent Kit, the assay enables high-throughput, sample-to-answer testing with PCR-equivalent performance and minimal hands-on time, the firm said in a statement.

It is authorized for use on a variety of swab samples with the Agilent Bravo BenchCel DB liquid handling platform. Agilent and Mammoth intend to comarket the assay.

"This emergency use authorization is another important step towards our mission to harness the full potential of CRISPR to improve lives," said Janice Chen, cofounder and chief technology officer of Mammoth Biosciences.

Mammoth's SARS-CoV-2 DETECTR Reagent Kit was authorized in September 2020 for use in high-complexity labs. The firm raised $195 million in September 2021 through Series C and D financing rounds.

The project was supported by the National Institutes of Health Rapid Acceleration of Diagnostics program as well as the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, and Department of Health and Human Services.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.